e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Novel drugs and biomarkers in respiratory medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Experimental airways hyperreactivity and modulation of glutamatergic and nitrergic signalling
M. Antosová, A. Strapková (Martin, Slovakia)
Source:
Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Session:
Novel drugs and biomarkers in respiratory medicine
Session type:
Thematic Poster Session
Number:
739
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Antosová, A. Strapková (Martin, Slovakia). Experimental airways hyperreactivity and modulation of glutamatergic and nitrergic signalling. Eur Respir J 2013; 42: Suppl. 57, 739
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Incorrect inhaler technique is common in patients with COPD – Data from the TIE study
A prospective study of the effect of carbocysteine lysine salt on COPD exacerbations with or without inhaled steroids
The novel elastase inhibitor BAY 85-8501 provides a new approach in the treatment of pulmonary diseases
Related content which might interest you:
Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli
Source: Eur Respir J 2006 Oct 01;28(4):703-711
Year: 2006
Methacholine hyperresponsiveness was related to nitric oxide regulation in growth restricted preterm born children
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016
Characteristics of exercise induced bronchoconstriction in asthmatic children according to exhaled nitric oxide
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016
Age – related impairment of nitric oxide involvement in regulation of airways smooth muscle tone
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Interaction of the glutamatergic and nitrergic signaling system in the airway hyperreactivity
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Nitric oxide and neurokinins effects in the control of baseline airway tonus in guinea pigs in physiological and chronic inflammatory situations
Source: Eur Respir J 2005; 26: Suppl. 49, 558s
Year: 2005
Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions
Source: Eur Respir J 2009; 33: 844-851
Year: 2009
Different effects of cNOS and iNOS-derived nitric oxide in lung mechanics in a model of chronic airway inflammation in guinea pigs: modulation by neuropeptides
Source: Eur Respir J 2005; 26: Suppl. 49, 558s
Year: 2005
Neurokinins and nitric oxide modulate airway remodeling in a model of lung allergic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005
Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Nitric oxide is a poor bronchodilator but reduces release of leukotrienes in the peripheral airways
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005
Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease?
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Decreased airway eosinophilic inflammation, hypersecretion and remodeling in mice lacking all nitric oxide synthase isoforms
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Airway epithelial hemoglobin beta regulates ciliary endothelial NOS
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Airway and systemic nitric oxide pathway in COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Nitric oxide synthase inhibitors and guinea-pigs bronchial hyperreactivity evoked by toluene
Source: Eur Respir J 2005; 26: Suppl. 49, 367s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept